+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure



In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure



Journal of Applied Toxicology 24(4): 257-260



The benzamide compound metoclopramide (MCP) protects against cholinesterase inhibition by paraoxon (POX) both in vitro and in vivo. This study evaluates MCP-conferred protection of enzyme activity head to head against the therapeutic gold standard pralidoxime (PRX). Six groups of rats were used. All substances were applied i.p. daily for 5 days, followed by a 2-day rest. The 7-day cycle was repeated eight times. Group 1 received 100 nM POX, group 2 received 50 micro M MCP, group 3 received 100 nM POX + 50 micro M MCP, group 4 received 50 micro M PRX, group 5 received 100 nM POX + 50 micro M PRX and group 6 received saline. Red blood cell acetylcholinesterase (RBC-AChE) measurements were performed at baseline and on day 5 of each 7-day cycle. The sums of enzyme activities over time (weekly values expressed as % of baseline of 100%) were compared using the Mann-Whitney rank order test. A Bonferroni correction of 4 for multiple comparisons was applied. Paraoxon significantly reduced enzyme activities when compared with saline (Sigma = 535 +/- 25 vs 902 +/- 42). Metoclopramide conferred statistically significant in vivo protection from inhibition of RBC-AChE by POX (Sigma = 640 +/- 58). The extent of protection was significantly less than that conferred by the gold standard PRX (Sigma = 765 +/- 57). Metoclopramide, in addition to being less effective as an RBC-AChE protective agent, also caused a failure to thrive in the POX+MCP-exposed rats, as evidenced by the changes in body weight.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012194917

Download citation: RISBibTeXText

PMID: 15300712

DOI: 10.1002/jat.980


Related references

Pralidoxime protection of cholinesterase from inhibition by paraoxon in vivo. Anesthesia & Analgesia 94(2S Suppl.): S 323, 2002

In vivo protection of RBC-cholinesterase by metoclopramide from inhibition by paraoxon. Journal of Clinical Pharmacology 43(9): 1018, 2003

Metoclopramide protection of cholinesterase from paraoxon inhibition. Veterinary and Human Toxicology 45(5): 251-253, 2003

The influence of obidoxime, diacetylmonoxime, pralidoxime, and two less hydrophilic derivatives of pralidoxime upon the cholinesterase inhibition and the pressor effect by paraoxon in the rat. Toxicology and Applied Pharmacology 66(2): 244-251, 1982

Pralidoxime and l-lactate effects in vitro on the inhibition of acetylcholinesterase by paraoxon: pralidoxime does not confer superior protection. Journal of Applied Toxicology 21(1): 7-13, 2001

The reactivation effect of pralidoxime in human blood on parathion and paraoxon-induced cholinesterase inhibition. Daru 14(1): 37-43, 2006

Protective drugs in acute large-dose exposure to organophosphates: a comparison of metoclopramide and tiapride with pralidoxime in rats. Anesthesia and Analgesia 100(2): 382-386, 2005

Metoclopramide protects cholinesterase from inhibition by paraoxon. Anesthesia & Analgesia 94(2S Suppl.): S 288, 2002

Five oximes (K-27, K-33, K-48, Bl-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetyl cholinesterase inhibitied by paraoxon. Journal of Applied Toxicology 26(1): 64-71, 2006

Influence of obidoxime di acetyl mon oxime pralidoxime and 2 less hydrophilic derivatives of pralidoxime upon the cholin esterase inhibition and the pressor effect of paraoxon in the rat. Toxicology & Applied Pharmacology 66(2): 244-251, 1982

In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon. Journal of Applied Toxicology 23(1): 75-79, 2003

Reactivation of paraoxon-inactivated cholinesterase in the rat cerebral cortex by pralidoxime chloride. Nature 201(5032): 206, 1966

The organophosphate paraoxon has no demonstrable effect on the murine immune system following subchronic low dose exposure. International Journal of Immunopathology and Pharmacology 21(4): 891-901, 2009

The organophosphate paraoxon has no demonstrable effect on the murine immune system following subchronic low dose exposure. International Journal Of Immunopathology And Pharmacology: 4, 891-901, 2008

In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox). Journal of Applied Toxicology 23(6): 447-451, 2003